SCHEMBL6747157

SCHEMBL6747157

Cc1cccc(C2=CCC=C2c2cc(F)c(S(C)(=O)=O)c(F)c2)n1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TGFBR1 P36897 7/20 0.37
CCR1 P32246 1/20 0.37
CCR8 P51685 1/20 0.37
PTGS2 P35354 1/20 0.35
THRB P10828 2/20 0.35
HCRTR1 O43613 1/20 0.35
HCRTR2 O43614 1/20 0.35
CYP2A6 P11509 1/20 0.35
CASP1 P29466 1/20 0.34
ALDH1A1 P00352 3/20 0.33
HSD11B1 P28845 2/20 0.33
HPGD P15428 1/20 0.33
GHSR Q92847 1/20 0.33
MAPK14 Q16539 3/20 0.32
KDR P35968 2/20 0.32
KDM4E B2RXH2 2/20 0.32
GAA P10253 2/20 0.32
GLA P06280 1/20 0.32
TDP1 Q9NUW8 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6745114 0.79 SDHB (0.38) PTGS2CASP1MAPK14
SCHEMBL6745120 0.78 ACLY (0.35) PTGS2CASP1ALDH1A1HPGDKDM4E
SCHEMBL6744532 0.78 CCR1 (0.35) TGFBR1CCR1CCR8PTGS2THRB
SCHEMBL6746349 0.78 PTGS2 (0.41) PTGS2CASP1
SCHEMBL6744707 0.78 HPGD (0.39) PTGS2CASP1ALDH1A1HPGDKDM4E
SCHEMBL6746753 0.77 PTGS2 (0.45) PTGS2THRBCASP1ALDH1A1KDM4E
SCHEMBL6746288 0.77 CASP1 (0.35) PTGS2CASP1
SCHEMBL6744598 0.76 PTGS2 (0.39) PTGS2CASP1CYP2C19
SCHEMBL6746730 0.76 PTGS2 (0.38) PTGS2CASP1HSD11B1
SCHEMBL6744935 0.76 PTGS2 (0.36) PTGS2CASP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6699884-B2 ANTIINFLAMMATORY CYCLOOXYGENASE INHIBITORS. PHARMACIA CORPORATION 2004-03-02 US claimed
US-6699884-B2 ANTIINFLAMMATORY CYCLOOXYGENASE INHIBITORS. PHARMACIA CORPORATION 2004-03-02 US disclosed